BeiGene Ltd - ADR (BGNE) Dividend History

BeiGene Ltd is a clinical-stage biopharmaceutical company engaged in the discovery & development of molecularly targeted & immuno-oncology drugs for the treatment of cancer. Its product includes BGB-3111, BGB-283 and BGB-290 and one immuno-oncology agent.

Last update 09/24/2023


Dividend Yield Summary

  2018 2019 2020 2021 2022 2023
Dividends - - - - - -
Average Price 153.88 140.32 208.18 331.75 180.92 224.79
Yield - - - - - -
• The above Dividend, Average Price, and Yield values for 2023 are year-to-date.

Dividend History

No history of dividends
Date Amount Per Share Note